Form 4: Kiromic Biopharma CFO Brian Hungerford Acquires 1,000 Shares

Kiromic Biopharma's CFO, Brian Hungerford, purchased 1,000 shares of common stock at $2.60 per share on June 13, 2024.

Summary

• On June 13, 2024, Brian Hungerford, the CFO of Kiromic Biopharma, Inc., acquired 1,000 shares of the company's common stock.
• The purchase price was $2.60 per share.
• Following the transaction, Hungerford directly owns 58,933 shares of Kiromic Biopharma.

Sentiment

Score: 5

Explanation: Neutral sentiment. This is a routine transaction disclosure. The purchase itself is a small amount relative to the CFO's existing holdings.

Positives

• The CFO's purchase of company stock could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. These filings are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

• The stock purchase could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Kiromic Biopharma, Brian Hungerford, CFO, stock purchase, Form 4, KRBP, beneficial ownership